These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16876371

  • 41. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
    Glatz M, Fingerle V, Wilske B, Ambros-Rudolph C, Kerl H, Müllegger RR.
    Dermatology; 2008; 216(2):93-103. PubMed ID: 18216470
    [Abstract] [Full Text] [Related]

  • 42. Antigenicity of borrelial protein BBK32 fragments in early Lyme borreliosis.
    Lahdenne P, Sarvas H, Kajanus R, Eholuoto M, Sillanpää H, Seppälä I.
    J Med Microbiol; 2006 Nov; 55(Pt 11):1499-1504. PubMed ID: 17030908
    [Abstract] [Full Text] [Related]

  • 43. Clinical features and specific immunological response to Borrelia afzelii in patients with acrodermatitis chronica atrophicans.
    Flisiak I, Schwartz RA, Chodynicka B.
    J Med; 1999 Nov; 30(3-4):267-78. PubMed ID: 17312680
    [Abstract] [Full Text] [Related]

  • 44. [The polymerase chain reaction evaluation of Borrelia burgdorferi DNA presence in peripheral blood of patients with Lyme disease].
    Kondrusik M, Grygorczuk S, Skotarczak B, Wodecka B, Pancewicz S, Zajkowska J, Swierzbińska R, Hermanowska-Szpakowicz T.
    Pol Merkur Lekarski; 2004 Dec; 17(102):593-6. PubMed ID: 15771130
    [Abstract] [Full Text] [Related]

  • 45. Identification of Borrelia burgdorferi ribosomal protein L25 by the phage surface display method and evaluation of the protein's value for serodiagnosis.
    Mueller M, Bunk S, Diterich I, Weichel M, Rauter C, Hassler D, Hermann C, Crameri R, Hartung T.
    J Clin Microbiol; 2006 Oct; 44(10):3778-80. PubMed ID: 17021109
    [Abstract] [Full Text] [Related]

  • 46. [Laboratory diagnosis of Lyme borreliosis].
    Kristiansen BE, Grude N, Tveten Y, Emmert A.
    Tidsskr Nor Laegeforen; 2009 Oct 22; 129(20):2132-4. PubMed ID: 19855455
    [No Abstract] [Full Text] [Related]

  • 47. Microbiological and serological diagnosis of Lyme borreliosis.
    Wilske B, Fingerle V, Schulte-Spechtel U.
    FEMS Immunol Med Microbiol; 2007 Feb 22; 49(1):13-21. PubMed ID: 17266710
    [Abstract] [Full Text] [Related]

  • 48. [Recombinant OspC identification and antigenicity detection from Borrelia burgdorferi PD91 in China].
    Chen J, Wan KL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Oct 22; 24(10):917-9. PubMed ID: 14575608
    [Abstract] [Full Text] [Related]

  • 49. Detection of antibodies to Borrelia burgdorferi in naturally infected horses in the USA by enzyme-linked immunosorbent assay using whole-cell and recombinant antigens.
    Magnarelli L, Fikrig E.
    Res Vet Sci; 2005 Oct 22; 79(2):99-103. PubMed ID: 15924926
    [Abstract] [Full Text] [Related]

  • 50. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays.
    Xu Y, Bruno JF, Luft BJ.
    Microb Pathog; 2008 Oct 22; 45(5-6):403-7. PubMed ID: 18976702
    [Abstract] [Full Text] [Related]

  • 51. [Evidence of Borrelia burgdorferi spirochetes in patients with early disseminated Lyme borreliosis].
    Schwarzová K, Holecková K, Kostanová Z.
    Klin Mikrobiol Infekc Lek; 2009 Apr 22; 15(2):40-3. PubMed ID: 19488960
    [Abstract] [Full Text] [Related]

  • 52. [The laboratory diagnosis of Borrelia burgdorferi infection].
    Vogt A.
    Fortschr Med; 1990 Apr 10; 108(10):194-7. PubMed ID: 2187779
    [Abstract] [Full Text] [Related]

  • 53. [The importance of recombinant proteins of West Siberian isolates of Borrelia burgdorferi S.L. for serological diagnostic of ixodic tick borreliosis].
    Karavayev VS, Genina ES, Ryabchenko AV, Beklemoschev AB.
    Klin Lab Diagn; 2014 Jun 10; (6):44-8. PubMed ID: 25335400
    [Abstract] [Full Text] [Related]

  • 54. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus.
    Eisendle K, Grabner T, Kutzner H, Zelger B.
    Arch Dermatol; 2008 May 10; 144(5):591-8. PubMed ID: 18490585
    [Abstract] [Full Text] [Related]

  • 55. [Biologic diagnosis of Lyme borreliosis].
    Remy V.
    Med Mal Infect; 2007 May 10; 37(7-8):410-21. PubMed ID: 17360138
    [Abstract] [Full Text] [Related]

  • 56. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
    Nyman D, Willén L, Jansson C, Carlsson SA, Granlund H, Wahlberg P.
    Clin Microbiol Infect; 2006 May 10; 12(5):496-7. PubMed ID: 16643532
    [No Abstract] [Full Text] [Related]

  • 57. [Actual diagnostic possibilities of Lyme borreliosis].
    Hermanowska-Szpakowicz T, Swierzbińska R, Zajkowska JM, Izycka-Herman A, Pancewicz SA, Kondrusik M.
    Pol Merkur Lekarski; 2000 Jan 10; 7(43):69-71. PubMed ID: 10765660
    [Abstract] [Full Text] [Related]

  • 58. Anetoderma and borreliosis: is there a pathogenetic relationship?
    Hofer T, Goldenberger D, Itin PH.
    Eur J Dermatol; 2003 Jan 10; 13(4):399-401. PubMed ID: 12948924
    [Abstract] [Full Text] [Related]

  • 59. Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis.
    Jones KL, Muellegger RR, Means TK, Lee M, Glickstein LJ, Damle N, Sikand VK, Luster AD, Steere AC.
    Clin Infect Dis; 2008 Jan 01; 46(1):85-92. PubMed ID: 18171218
    [Abstract] [Full Text] [Related]

  • 60. C6-peptide serology as diagnostic tool in neuroborreliosis.
    Tjernberg I, Schön T, Ernerudh J, Wistedt AC, Forsberg P, Eliasson I.
    APMIS; 2008 May 01; 116(5):393-9. PubMed ID: 18452429
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.